SOX11、CCND1、BCL1/IgH和IgH-VDJ：套细胞淋巴瘤中微小残留病标志物的较量？ - Suppr

Suppr

超能文献

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?

作者信息

Simonsen Anita T, Schou Marie, Sørensen Camilla D, Bentzen Hans H N, Nyvold Charlotte G

机构信息

a Department of Hematology , Aarhus University Hospital , Aarhus , Denmark.

出版信息

Leuk Lymphoma. 2015;56(9):2724-7. doi: 10.3109/10428194.2015.1004672. Epub 2015 Feb 11.

DOI:10.3109/10428194.2015.1004672

PMID:25629991

Abstract

摘要

相似文献

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?

Leuk Lymphoma. 2015;56(9):2724-7. doi: 10.3109/10428194.2015.1004672. Epub 2015 Feb 11.

SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.

Med Oncol. 2018 Mar 8;35(4):49. doi: 10.1007/s12032-018-1111-x.

Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma.

Virchows Arch. 2024 Aug;485(2):323-334. doi: 10.1007/s00428-024-03813-9. Epub 2024 May 11.

Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement.

Ann Hematol. 2024 Feb;103(2):667-669. doi: 10.1007/s00277-023-05514-w. Epub 2023 Oct 26.

The role of SOX11 in mantle cell lymphoma.

Leuk Res. 2013 Nov;37(11):1412-9. doi: 10.1016/j.leukres.2013.07.039. Epub 2013 Aug 16.

Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.

J Immunol Methods. 2014 Apr;406:131-6. doi: 10.1016/j.jim.2014.03.004. Epub 2014 Mar 13.

A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.

Eur J Haematol. 2012 Nov;89(5):385-94. doi: 10.1111/j.1600-0609.2012.01837.x. Epub 2012 Aug 21.

Sensitive quantification of the intronless SOX11 mRNA from lymph nodes biopsies in mantle cell lymphoma.

Leuk Res. 2019 Mar;78:1-2. doi: 10.1016/j.leukres.2019.01.001. Epub 2019 Jan 3.

Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.

J Clin Pathol. 2003 Oct;56(10):798-800. doi: 10.1136/jcp.56.10.798.

SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis.

Leukemia. 2013 Dec;27(12):2388-91. doi: 10.1038/leu.2013.141. Epub 2013 May 7.

引用本文的文献

Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside.

Exp Hematol Oncol. 2022 Sep 3;11(1):50. doi: 10.1186/s40164-022-00300-2.

Advances in the assessment of minimal residual disease in mantle cell lymphoma.

J Hematol Oncol. 2020 Sep 24;13(1):127. doi: 10.1186/s13045-020-00961-8.

SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.

Med Oncol. 2018 Mar 8;35(4):49. doi: 10.1007/s12032-018-1111-x.

SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.

Int J Hematol. 2017 Aug;106(2):212-220. doi: 10.1007/s12185-017-2236-y. Epub 2017 Apr 20.

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.

Oncotarget. 2016 Jul 26;7(30):48692-48731. doi: 10.18632/oncotarget.8961.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验